Enguerran Mouly

1.8k total citations
15 papers, 907 citations indexed

About

Enguerran Mouly is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Enguerran Mouly has authored 15 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Enguerran Mouly's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (3 papers). Enguerran Mouly is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (3 papers). Enguerran Mouly collaborates with scholars based in France, Netherlands and Mali. Enguerran Mouly's co-authors include Laurianne Scourzic, Olivier Bernard, François M. Lemoine, Karine Chemin, Raphaël Borie, Hai V. Nguyen, Raphaël Ceccaldi, Jérôme Larghero, David Klatzmann and Qing‐Shuo Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Enguerran Mouly

15 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enguerran Mouly France 11 519 286 173 154 115 15 907
Todd M. Kinsella United States 7 593 1.1× 238 0.8× 235 1.4× 141 0.9× 71 0.6× 12 990
Alexander L. Kovalchuk United States 21 616 1.2× 398 1.4× 291 1.7× 87 0.6× 174 1.5× 53 1.2k
Elio Liboi Italy 15 379 0.7× 262 0.9× 172 1.0× 100 0.6× 73 0.6× 31 764
Meino Rohlfs Germany 16 309 0.6× 338 1.2× 132 0.8× 149 1.0× 79 0.7× 41 746
Konstantin Khetchoumian France 15 767 1.5× 320 1.1× 120 0.7× 130 0.8× 49 0.4× 17 1.1k
Irene Shostak Canada 10 441 0.8× 428 1.5× 150 0.9× 75 0.5× 81 0.7× 10 902
Scott M. Krummey United States 16 259 0.5× 537 1.9× 189 1.1× 110 0.7× 87 0.8× 37 1.0k
Xiaolong Liu China 18 535 1.0× 711 2.5× 273 1.6× 72 0.5× 89 0.8× 37 1.2k
Lillian Sun United States 8 344 0.7× 371 1.3× 146 0.8× 132 0.9× 45 0.4× 16 760
Reiner Schulte Germany 9 422 0.8× 315 1.1× 169 1.0× 35 0.2× 166 1.4× 14 871

Countries citing papers authored by Enguerran Mouly

Since Specialization
Citations

This map shows the geographic impact of Enguerran Mouly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enguerran Mouly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enguerran Mouly more than expected).

Fields of papers citing papers by Enguerran Mouly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enguerran Mouly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enguerran Mouly. The network helps show where Enguerran Mouly may publish in the future.

Co-authorship network of co-authors of Enguerran Mouly

This figure shows the co-authorship network connecting the top 25 collaborators of Enguerran Mouly. A scholar is included among the top collaborators of Enguerran Mouly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enguerran Mouly. Enguerran Mouly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jean, Philippe, Fabienne Wong Jun Tai, Amrit Singh‐Estivalet, et al.. (2023). Single-cell transcriptomic profiling of the mouse cochlea: An atlas for targeted therapies. Proceedings of the National Academy of Sciences. 120(26). e2221744120–e2221744120. 34 indexed citations
2.
Della-Valle, Véronique, Damien Roos‐Weil, Laurianne Scourzic, et al.. (2020). Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice. Blood Cancer Journal. 10(3). 38–38. 10 indexed citations
3.
Mouly, Enguerran, Cécile Planquette, Emilie Rousseau, & Rémi Delansorne. (2018). Abstract 1890: Inecalcitol respectively induces or increases CD38 expression at the surface of CD38- or CD38+ AML cell lines representative of all 9 FAB subtypes except M6. Cancer Research. 78(13_Supplement). 1890–1890. 3 indexed citations
4.
Mouly, Enguerran, Hussein Ghamlouch, Véronique Della-Valle, et al.. (2018). B-cell tumor development in Tet2-deficient mice. Blood Advances. 2(6). 703–714. 37 indexed citations
5.
Mouly, Enguerran, Cécile Planquette, Emilie Rousseau, & Rémi Delansorne. (2018). Inecalcitol Enhances Daratumumab-Induced Antibody-Dependent Cell Cytotoxicity Towards Multiple Myeloma and Acute Myeloid Leukemia Cell Lines. Blood. 132(Supplement 1). 1447–1447. 1 indexed citations
6.
Scourzic, Laurianne, Enguerran Mouly, & Olivier Bernard. (2015). TET proteins and the control of cytosine demethylation in cancer. Genome Medicine. 7(1). 9–9. 165 indexed citations
7.
Lecourt, Séverine, Enguerran Mouly, Audrey Cras, et al.. (2013). A Prospective Study of Bone Marrow Hematopoietic and Mesenchymal Stem Cells in Type 1 Gaucher Disease Patients. PLoS ONE. 8(7). e69293–e69293. 27 indexed citations
8.
Karlin, Lionel, Stéphanie Harel, Enguerran Mouly, et al.. (2012). The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo. Haematologica. 97(7). 1101–1109. 39 indexed citations
9.
Nguyen, Hai V., Enguerran Mouly, Karine Chemin, et al.. (2012). The Ets-1 transcription factor is required for Stat1-mediated T-bet expression and IgG2a class switching in mouse B cells. Blood. 119(18). 4174–4181. 35 indexed citations
10.
Ceccaldi, Raphaël, Kalindi Parmar, Enguerran Mouly, et al.. (2012). Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor Cells. Cell stem cell. 11(1). 36–49. 231 indexed citations
11.
Mouly, Enguerran, Karine Chemin, Hai V. Nguyen, et al.. (2010). The Ets-1 transcription factor controls the development and function of natural regulatory T cells. The Journal of Experimental Medicine. 207(10). 2113–2125. 92 indexed citations
12.
Mouly, Enguerran, Céline Dorival, Françoise Pflumio, et al.. (2006). CD4 regulation in human lymphoid non-T-cells: A role for the silencer element. Molecular Immunology. 44(4). 267–275. 2 indexed citations
13.
Dupuy, Franck P., Enguerran Mouly, Mariana Mesel‐Lemoine, et al.. (2005). Lentiviral transduction of human hematopoietic cells by HIV‐1‐ and SIV‐based vectors containing a bicistronic cassette driven by various internal promoters. The Journal of Gene Medicine. 7(9). 1158–1171. 40 indexed citations
14.
Cohen, Nicolas, Enguerran Mouly, Haïfa Hamdi, et al.. (2005). GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood. 107(5). 2037–2044. 133 indexed citations
15.
Marodon, Gilles, et al.. (2003). Specific transgene expression in human and mouse CD4+cells using lentiviral vectors with regulatory sequences from theCD4 gene. Blood. 101(9). 3416–3423. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026